Our analysis of the TCGA-BLCA dataset revealed a positive correlation between SMAD6 and YTHDC1 expression (Fig. 6a, left), which is consistent with SMAD6 being a downstream effector of YTHDC1 in UCB. Here, SMAD6 is linked to bladder transitional cell carcinoma.